Stock Roundup: Key Movements in NASDAQ-Listed Companies

A look at recent stock movements and analyst ratings for NASDAQ-listed companies, including Microsoft, Neumora Therapeutics, and Zions Bancorporation.

Stock Roundup: Key Movements in NASDAQ-Listed Companies

Here's a quick rundown of recent activity surrounding several companies listed on the NASDAQ, covering short interest fluctuations, analyst ratings, and earnings expectations.

Short Interest Updates

First up, the Western Asset Short Duration Income ETF (NASDAQ:WINC) saw a significant dip in short interest during February. Numbers show a 33.3% decrease, dropping from 900 shares on January 31st to just 600 shares as of February 15th. The average daily trading volume sits at 2,800 shares.

On the other hand, Zions Bancorporation, National Association (NASDAQ:ZION) experienced a surge in short interest. February saw a 27.1% increase, with short interest totaling 5,200,000 shares compared to 4,090,000 shares at the end of January. This represents about 3.6% of the company's total shares sold short.

Chart showing fluctuating stock prices over time.

Analyst Ratings and Coverage

Neumora Therapeutics (NASDAQ:NMRA) received a reaffirmation of its "buy" rating from Needham & Company LLC, with a target price of $5.00. However, it's worth noting that other analysts have mixed opinions, with JPMorgan Chase & Co. recently lowering their rating on the stock. This highlights the diverse perspectives on Neumora's potential.

NeuroMetrix (NASDAQ:NURO), a medical device company, recently had its coverage initiated by StockNews.com. Unfortunately for NeuroMetrix, the firm issued a "sell" rating. The stock opened at $4.38 on Tuesday, showing a slight increase of 0.5%. Key financial metrics include a market cap of $8.99 million and a negative P/E ratio.

A professional analyst looking at a computer screen showing stock data.

Holdings and Earnings

Successful Portfolios LLC made a slight adjustment to its holdings in Microsoft Co. (NASDAQ:MSFT) during the fourth quarter. According to their recent Form 13F filing with the SEC, they reduced their position by 0.4%, selling 48 shares and leaving them with a total of 12,606 shares.

Finally, investors are awaiting the quarterly earnings announcement from OFS Credit (NASDAQ:OCCI), expected before the market opens on Thursday, March 6th. Analysts are projecting earnings of $0.33 per share and revenue of $9.59 million for the quarter.

Close-up image of stock ticker display board.

These updates provide a snapshot of the dynamic landscape of the stock market and the various factors influencing investment decisions.

Share this article: